|
Volumn 38, Issue 5, 2001, Pages 1074-1081
|
Lamivudine is effective for the treatment of reactivation of hepatitis b virus and fulminant hepatic failure in renal transplant recipients
a a a a a a |
Author keywords
Fulminant hepatic failure; Hepatitis B virus (HBV); Hepatitis B virus (HBV) DNA; Lamivudine; Renal transplantation
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIGEN;
IMMUNOSUPPRESSIVE AGENT;
LAMIVUDINE;
LYMPHOCYTE ANTIBODY;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISOLONE;
TACROLIMUS;
ADOLESCENT;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
DRUG EFFICACY;
FEMALE;
HEPATITIS B;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LIVER FAILURE;
MALE;
MORTALITY;
POSTOPERATIVE COMPLICATION;
PREVALENCE;
SEROCONVERSION;
VIRUS REACTIVATION;
|
EID: 0034748142
PISSN: 02726386
EISSN: None
Source Type: Journal
DOI: 10.1053/ajkd.2001.28607 Document Type: Article |
Times cited : (63)
|
References (34)
|